rs78468999

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001080414.4(CCDC88C):​c.1878G>C​(p.Lys626Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,613,400 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. K626K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 2 hom. )

Consequence

CCDC88C
NM_001080414.4 missense

Scores

8
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.674

Publications

4 publications found
Variant links:
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
CCDC88C Gene-Disease associations (from GenCC):
  • hydrocephalus, nonsyndromic, autosomal recessive 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • spinocerebellar ataxia type 40
    Inheritance: AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01115182).
BP6
Variant 14-91313938-C-G is Benign according to our data. Variant chr14-91313938-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 447014.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC88CNM_001080414.4 linkc.1878G>C p.Lys626Asn missense_variant Exon 15 of 30 ENST00000389857.11 NP_001073883.2 Q9P219-1B4DZB8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC88CENST00000389857.11 linkc.1878G>C p.Lys626Asn missense_variant Exon 15 of 30 5 NM_001080414.4 ENSP00000374507.6 Q9P219-1
CCDC88CENST00000557507.1 linkn.*5G>C downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00110
AC:
167
AN:
151968
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000582
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.00472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00134
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00113
AC:
281
AN:
248870
AF XY:
0.00115
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.000493
Gnomad ASJ exome
AF:
0.000994
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.00376
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.00231
GnomAD4 exome
AF:
0.00108
AC:
1577
AN:
1461314
Hom.:
2
Cov.:
32
AF XY:
0.00106
AC XY:
769
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.000425
AC:
19
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00130
AC:
34
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000800
AC:
69
AN:
86258
European-Finnish (FIN)
AF:
0.00421
AC:
223
AN:
53012
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00104
AC:
1161
AN:
1111870
Other (OTH)
AF:
0.00106
AC:
64
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
103
206
308
411
514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00110
AC:
167
AN:
152086
Hom.:
0
Cov.:
32
AF XY:
0.00114
AC XY:
85
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41490
American (AMR)
AF:
0.000458
AC:
7
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3466
East Asian (EAS)
AF:
0.000583
AC:
3
AN:
5144
South Asian (SAS)
AF:
0.000624
AC:
3
AN:
4810
European-Finnish (FIN)
AF:
0.00472
AC:
50
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00134
AC:
91
AN:
67996
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00121
Hom.:
0
Bravo
AF:
0.000502
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000594
AC:
5
ExAC
AF:
0.00109
AC:
132
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.000711

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 29, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
Eigen
Uncertain
0.27
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
0.67
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.2
D
REVEL
Benign
0.10
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.019
D
Polyphen
0.99
D
Vest4
0.49
MutPred
0.40
Loss of ubiquitination at K626 (P = 0.0074);
MVP
0.62
MPC
0.60
ClinPred
0.057
T
GERP RS
2.7
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.32
gMVP
0.25
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78468999; hg19: chr14-91780282; API